Main Session
Sep
29
SS 28 - GU 6: Revelations in Renal Radiotherapy
264 - Ultra-Hypofractionated Stereotactic Ablative Body Radiotherapy (SABR) for Primary Renal Cell Carcinoma: Pooled Outcomes from the FASTRACK and FASTRACK II Clinical Trials
Presenter(s)
Shankar Siva, PhD, MBBS, FRANZCR - Peter MacCallum Cancer Centre, Parkville, VIC